Statements of Cash Flows (USD $)	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
Operating activities:
Net loss	$ (6,612,209)	$ (2,613,596)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:
Goodwill impairment		2,488,708
Depreciation and amortization	1,265,049	1,042
Interest expense	1,015,917	781
Loss on sales of assets	15,646
Changes in certain assets and liabilities:
Accounts receivable	(499,367)	(14,428)
Inventory	2,481,794
Other current assets	(17,545)	(172,110)
Accounts payable and accrued expenses	933,301	292,188
Accounts payable - related party	(428,835)	33,890
Deferred revenue	(259,678)	(8,835)
Other long-term liabilities	388,350
Net cash (used in) provided by operating activities	(1,717,577)	7,640
Investing activities:
Investment in marketable securities	(16,237,359)
Proceeds from the sale of property, plant and equipment	622,465
Cash acquired in acquisition	103,222
Net cash (used in) provided by investing activities	(15,511,672)
Financing activities:
Line of credit, net change	998,992
Repayments on long-term debt	(1,064,004)
Net cash used in financing activities	(65,012)
Effect of exchange rate changes on cash	(1,601)
Increase (decrease) in cash	(17,295,862)	7,640
Cash and cash equivalents at beginning of year	19,032,392	8,608
Cash and cash equivalents at end of period	1,736,530	16,248
Non-cash transactions:
Convertible note converted to stock	6,563,555
Convertible note issued related to acquisition	6,500,000
Promissory note issued related to acquisition	4,000,000
Stock issued related to acquisition	$ 1,308,763